What changed between revision 1 and revision 2, compared over the article's markdown source with its frontmatter — so a change to status, evidence or reversibility shows up as the edit it is.
Older · revision 1
Import· initial corpus import, not an edit
Initial import of content/julian-savulescu.md — the filesystem corpus, unchanged. Not an edit.
9.1 kB
Revision 1
Revision 2
lines 7–14 → 7–136 unchanged lines not shown
categories: ["people", "society"]categories: ["people", "society"]tags: ["bioethics", "enhancement", "embryo selection", "moral enhancement", "philosophy"]tags: ["bioethics", "enhancement", "embryo selection", "moral enhancement", "philosophy"]summary: "Australian bioethicist who formulated procreative beneficence and, with Ingmar Persson, the argument for moral bioenhancement; the leading academic advocate of human enhancement."summary: "Australian bioethicist who formulated procreative beneficence and, with Ingmar Persson, the argument for moral bioenhancement; the leading academic advocate of human enhancement."updated: "2026-07-27"updated: "2026-08-23"issues: ["Reception section calls him among the most cited living bioethicists with no source."]------ ```infobox```infoboxlines 20–26 → 19–255 unchanged lines not shown
{ "label": "Education", "value": "MBBS and PhD, Monash University" }, { "label": "Education", "value": "MBBS and PhD, Monash University" }, { "label": "Known for", "value": "Procreative beneficence", "link": "/wiki/procreative-beneficence" }, { "label": "Known for", "value": "Procreative beneficence", "link": "/wiki/procreative-beneficence" }, { "label": "Field", "value": "Practical ethics" }, { "label": "Field", "value": "Practical ethics" }, { "label": "Affiliation", "value": "Oxford Uehiro Centre; National University of Singapore" }, { "label": "Affiliation", "value": "National University of Singapore; University of Oxford" }, { "label": "Doctoral adviser", "value": "Peter Singer" } { "label": "Doctoral adviser", "value": "Peter Singer" } ] ]}}lines 39–52 → 38–5312 unchanged lines not shown
working on rationality and end-of-life decision-making. He took the Uehiro Chair in Practical Ethicsworking on rationality and end-of-life decision-making. He took the Uehiro Chair in Practical Ethicsat Oxford in 2002 and founded and directed the Oxford Uehiro Centre for Practical Ethics, whichat Oxford in 2002 and founded and directed the Oxford Uehiro Centre for Practical Ethics, whichbecame the main European base for analytic work on enhancement, neuroethics and research ethics. Hebecame the main European base for analytic work on enhancement, neuroethics and research ethics. Heedited the *Journal of Medical Ethics* for close to two decades. Since 2022 he has also held aedited the *Journal of Medical Ethics* for close to two decades. In August 2022 he moved hischair in medical ethics at the National University of Singapore, directing its Centre forprimary post to the National University of Singapore, where he is the Chen Su Lan CentennialBiomedical Ethics, and he leads a biomedical ethics group at the Murdoch Children's ResearchProfessor in Medical Ethics and directs its Centre for Biomedical Ethics, while retaining OxfordInstitute in Melbourne.and Melbourne affiliations, including a biomedical ethics group at the Murdoch Children's ResearchInstitute.[^nus2022] His output is unusually broad for the field: embryo selection, doping, organ donation, conscientiousHis output is unusually broad for the field: embryo selection, doping, organ donation, conscientiousobjection by clinicians, the ethics of research in emergencies, and during the pandemic a prominentobjection by clinicians, the ethics of research in emergencies, and the ethics of pandemicargument for human challenge trials of vaccines.response — with Dominic Wilkinson he edited *Pandemic Ethics: From COVID-19 to Disease X*(2023).[^pw2023] ## Procreative beneficence## Procreative beneficence lines 105–112 → 106–11352 unchanged lines not shown
## Reception## Reception Savulescu is among the most cited living bioethicists, and the Uehiro Centre trained a generation ofThe Uehiro Centre under Savulescu's direction trained a generation of researchers now working onresearchers now working on neuroethics, AI ethics and enhancement. His method is characteristicallyneuroethics, AI ethics and enhancement. His method is characteristicallyanalytic: state a principle, follow it to conclusions most readers dislike, and treat the discomfortanalytic: state a principle, follow it to conclusions most readers dislike, and treat the discomfortas data about the principle rather than a reason to abandon it. Admirers regard this as intellectualas data about the principle rather than a reason to abandon it. Admirers regard this as intellectualseriousness. Critics regard the same trait as a willingness to reach eugenic-sounding conclusionsseriousness. Critics regard the same trait as a willingness to reach eugenic-sounding conclusionslines 145–148 → 146–15132 unchanged lines not shown
[^ps2008]: `paper` Persson, I. and Savulescu, J. "The Perils of Cognitive Enhancement and the Urgent Imperative to Enhance the Moral Character of Humanity." *Journal of Applied Philosophy*, 2008. {A philosophical argument for a research direction; it reports no data on any intervention that alters moral behaviour.}[^ps2008]: `paper` Persson, I. and Savulescu, J. "The Perils of Cognitive Enhancement and the Urgent Imperative to Enhance the Moral Character of Humanity." *Journal of Applied Philosophy*, 2008. {A philosophical argument for a research direction; it reports no data on any intervention that alters moral behaviour.}[^harris2011]: `paper` Harris, J. "Moral Enhancement and Freedom." *Bioethics*, 2011.[^harris2011]: `paper` Harris, J. "Moral Enhancement and Freedom." *Bioethics*, 2011.[^sav2004]: `paper` Savulescu, J., Foddy, B. and Clayton, M. "Why we should allow performance enhancing drugs in sport." *British Journal of Sports Medicine*, 2004. {An argued policy position in a medical journal, not a study of what doping or its prohibition does to athletes.}[^sav2004]: `paper` Savulescu, J., Foddy, B. and Clayton, M. "Why we should allow performance enhancing drugs in sport." *British Journal of Sports Medicine*, 2004. {An argued policy position in a medical journal, not a study of what doping or its prohibition does to athletes.}[^nus2022]: `statement` "Julian Savulescu." Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore. {The institution's own profile; it dates the professorship and centre directorship to August 2022.}[^pw2023]: `book` Savulescu, J. and Wilkinson, D., eds. *Pandemic Ethics: From COVID-19 to Disease X*. Oxford University Press, 2023. {An edited collection with contributions from many authors; cited for the fact and scope of the editorship rather than for any single position.} removed, struck through added, underlinedLine numbers count the serialised markdown of each revision, frontmatter included.
137 lines are the same in both revisions, and 107 of them are not shown. Neither revision here is necessarily the current article — read Julian Savulescu for the text this wiki stands behind today.